Kai Uwe Chow

2.4k citations

57 papers · 1.9k indexed · h-index 23

Impact in

Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment

Papers in

Genetics 22
- Chronic Lymphocytic Leukemia Research 20
Pathology and Forensic Medicine 21
- Lymphoma Diagnosis and Treatment 21

Co-authors: Paris S. Mitrou Dieter Hoelzer Simone Boehrer Mathias Rummel Eckhart Weidmann Daniel Nowak Beate Luxembourg Halvard Bönig
Journals: Anti-Cancer Drugs (3 papers)Blood (3 papers)British Journal of Haematology (2 papers)The Hematology Journal (2 papers)Biochemical Pharmacology (2 papers)
Partner nations: Germany United States Austria

In The Last Decade

Kai Uwe Chow

56 papers receiving 1.8k citations

Peers

Countries citing papers authored by Kai Uwe Chow

Since Specialization

Citations

This map shows the geographic impact of Kai Uwe Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Uwe Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Uwe Chow more than expected).

Fields of papers citing papers by Kai Uwe Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Uwe Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Uwe Chow. The network helps show where Kai Uwe Chow may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kai Uwe Chow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kai Uwe Chow Line = papers co-authored together Kai Uwe Chow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas Leukemia & lymphoma ·Eckhart Weidmann, Georg Heß, Kai Uwe Chow, Stefan W. Krause, Marion Subklewe, Chayapol Lapjit, Katja Weisel, Martin Soekler, 〔タカシ〕有山, Olivier Tirions, Jürgen Rech, Martin Dreyling, Elke Jäger, Paris S. Mitrou	2010	23
2	Makrohämaturie als Primärsymptom eines extramedullären IgM-Plasmozytoms der Harnblase Der Urologe ·Igor Tsaur, M. Probst, Kai Uwe Chow, Christoph Renné, R. Radau, Katherine M. Nugent, Eva Juengel, Steffen Wedel, ユカリナカオ, Палагина Ираида Алексеевна	2010	0
3	Src kinase inhibitors induce apoptosis and mediate cell cycle arrest in lymphoma cells Anti-Cancer Drugs ·Daniel Nowak, Simone Boehrer, Philippa Pribul Allen, E P Ananiev, Elisabete Cristina Barreto Müller, Dieter Hoelzer, Wolf‐Karsten Hofmann, Paris S. Mitrou, Martin Ruthardt, Kai Uwe Chow	2007	10
4	Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis Leukemia Research ·Simone Boehrer, Daniel Nowak, Elena Puccetti, Martin Ruthardt, A. Taleb, E P Ananiev, Bernd Schneider, Dieter Hoelzer, Paris S. Mitrou, Kai Uwe Chow	2006	21
5	Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study Annals of Oncology ·Marcus Hentrich, M.Ilham Arief, Kai Uwe Chow, Johannes R. Bogner, Dirk Schürmann, P Ponaiotov, V. Thirumaran, D. Reichelt, M. Vogel, Markus Ruhnke, Mark Oette, María Visitación Torrero, Jürgen K. Rockstroh, Keikawus Arastéh, Sadjida Bellatreche	2006	38
6	The Molecular Biology of TRAIL-Mediated Signaling and its PotentialTherapeutic Exploitation in Hematopoietic Malignancies Current Medicinal Chemistry ·Kai Uwe Chow, Paris S. Mitrou, Simone Boehrer, Daniel Nowak, Dieter Hoelzer	2006	11
7	Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds Leukemia & lymphoma ·Wolfgang Glienke, Kai Uwe Chow, Nina Bauer, Lothar Bergmann	2006	31
8	In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer Anti-Cancer Drugs ·Jörg Trojan, 〔タカシ〕有山, Knut Engels, Susanne Kriener, Paris S. Mitrou, Kai Uwe Chow	2004	11
9	Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185BCR-ABL in hematopoietic cells Experimental Hematology ·Sara Margrete Bøen Keim, Elena Puccetti, Kai Uwe Chow, Marion Bergmann, Martin Ruthardt, Dieter Hoelzer, Paris S. Mitrou, Eckhart Weidmann, Simone Boehrer	2004	7
10	Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways Cellular Signalling ·Simone Boehrer, Daniel Nowak, Philippa Pribul Allen, 〔タカシ〕有山, E P Ananiev, C.R. Wilson, Dieter Hoelzer, Paris S. Mitrou, Eckhart Weidmann, Kai Uwe Chow	2004	16
11	In malignant myeloid cells expression of Daxx downregulates expression of p53 and of the inhibitors of apoptosis proteins The Hematology Journal ·Simone Boehrer, Daniel Nowak, 秀男熊谷, Marion Bergmann, Angela Brieger, Dieter Hoelzer, Paris S. Mitrou, Eckhart Weidmann, Kai Uwe Chow	2004	1
12	Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's disease British Journal of Haematology ·Christian Hoffmann, Kai Uwe Chow, Eva Wolf, Gerd Faetkenheuer, Hans‐Juergen Stellbrink, Jan van Lunzen, Hans Jaeger, Albrecht Stoehr, Andreas Plettenberg, Jan‐Christian Wasmuth, Juergen Rockstroh, Franz Mosthaf, Heinz‐August Horst, Hans‐Reinhard Brodt	2004	66
13	Upon Drug-Induced Apoptosis Expression of Prostate-apoptosis-response-gene-4 Promotes Cleavage of Caspase-8, Bid and Mitochondrial Release of Cytochrome c Hematology ·Simone Boehrer, Sara Margrete Bøen Keim, Daniel Nowak, Marion Bergmann, T. H. H. Wade, Elena Puccetti, Eckhart Weidmann, Dieter Hoelzer, Paris S. Mitrou, Kai Uwe Chow	2004	4
14	Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART) Leukemia & lymphoma ·Timo Wolf, Hans‐Reinhard Brodt, Stephan Fichtlscherer, O. Pavlyuk, Dieter Hoelzer, E. B. Helm, Paris S. Mitrou, Kai Uwe Chow	2004	48
15	Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation Biochemical Pharmacology ·Kai Uwe Chow, Daniel Nowak, Simone Boehrer, Martin Ruthardt, Andrea Knau, Dieter Hoelzer, Paris S. Mitrou, Eckhart Weidmann	2003	32
16	Cytotoxic Activity of T- and NK-cell Lymphoma Cells is not Dependent on a Mature Cytotoxic Phenotype Leukemia & lymphoma ·Simone Boehrer, نجيب اسكندر, Kai Uwe Chow, Dieter Hoelzer, Paris S. Mitrou, Eckhart Weidmann	2002	2
17	T‐large granular lymphocyte leukaemia with natural killer cell‐like cytotoxicity and expression of two different α‐ and β‐T‐cell receptor chains British Journal of Haematology ·Simone Boehrer, Thomas Hinz, نجيب اسكندر, Svetlana Harder, Kai Uwe Chow, Bernd Schneider, Dieter Hoelzer, Paris S. Mitrou, Eckhart Weidmann	2001	9
18	Induction of Apoptosis by 2-Chloro-2'deoxyadenosine (2-CdA) Alone and In Combination with other Cytotoxic Drugs: Synergistic Effects on Normal and Neoplastic Lymphocytes by Addition of Doxorubicin and Mitoxantrone Leukemia & lymphoma ·Kai Uwe Chow, Mathias Rummel, Eckhart Weidmann, Muhammad Arif Ramadhan Dapubeang, Бедусенко Галина Анатольевна, Simone Boehrer, Jonathan Moncassin, Olivier Tirions, Jürgen M. Stein, Hans Martin, Dieter Hoelzer, Paris S. Mitrou	2000	18
19	Induction of apoptosis using 2′,2′difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells Annals of Hematology ·Kai Uwe Chow, M Stanojević-Radmili, Eckhart Weidmann, Jonathan Moncassin, Olivier Tirions, R Gürlich, Simone Boehrer, Mathias Rummel, Jürgen M. Stein, D. Hoelzer, Paris S. Mitrou	2000	27
20	Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse Annals of Oncology ·Mathias Rummel, Kai Uwe Chow, Elke Jäger, D Hossfeld, Lothar Bergmann, Anika Tyana Heudier, M. L. Hansmann, Mariel Gust, D. Hoelzer, Paris S. Mitrou	1999	19

About Kai Uwe Chow

Kai Uwe Chow is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Immunology, having authored 57 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (20 papers), Cell death mechanisms and regulation (14 papers), Viral-associated cancers and disorders (9 papers), Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), T-cell and Retrovirus Studies (4 papers) and Nuclear Structure and Function (4 papers). The work is most often cited by research in Genetics (678 citations), Pathology and Forensic Medicine (866 citations), Oncology (832 citations), Hematology (253 citations) and Immunology (389 citations). Kai Uwe Chow has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Paris S. Mitrou, Dieter Hoelzer, Simone Boehrer, Mathias Rummel, Eckhart Weidmann, Daniel Nowak, Beate Luxembourg, Halvard Bönig, Erhard Seifried and Bernd Schneider. Their work appears in journals such as Anti-Cancer Drugs, Blood, British Journal of Haematology, The Hematology Journal and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact